Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens

Yildiz R, Buyukberber S, Uner A, Yamac D, Coskun U, Kaya AO, Ozturk B, Yaman E, Benekli M.

Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. Cancer Invest.

2010 Jan;28(1):33-7. doi: 10.3109/07357900802562996. PubMed PMID: 19995229.

Related Articles

Serum and ascitic fluid nitrate levels in patients with cirrhosis.

21 October 2020

Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. 

21 October 2020

A case of Sweet’s syndrome developed after the treatment of herpes simplex infection in a metastatic breast cancer patient.

21 October 2020

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

21 October 2020
Back to top button
0312 229 20 55